Lancet Oncology, 20, 1273-1285 Lancet oncology, 20(9), 1273-1285. Elsevier Science The Lancet Oncology, 20(9), 1273-1285 PORTEC study group 2019, ' Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3) : patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial ', The Lancet Oncology, vol. 20, no. 9, pp. 1273-1285 . https://doi.org/10.1016/S1470-2045(19)30395-X The Lancet Oncology Lancet Oncology, 20(9), 1273-1285. ELSEVIER SCIENCE INC Lancet Oncology, 20, 9, pp. 1273-1285
Knoth, J, Pötter, R, Jürgenliemk-Schulz, I M, Haie-Meder, C, Fokdal, L, Sturdza, A, Hoskin, P, Mahantshetty, U, Segedin, B, Bruheim, K, Wiebe, E, Rai, B, Cooper, R, van der Steen-Banasik, E, van Limbergen, E, Pieters, B R, Sundset, M, Tan, L T, Nout, R A, Tanderup, K, Kirisits, C, Nesvacil, N, Lindegaard, J C & Schmid, M P 2020, ' Clinical and imaging findings in cervical cancer and their impact on FIGO and TNM staging – An analysis from the EMBRACE study ', Gynecologic Oncology, vol. 159, no. 1, pp. 136-141 . https://doi.org/10.1016/j.ygyno.2020.07.007 Gynecologic Oncology, 159(1), 136-141. Academic Press Gynecologic oncology, 159(1), 136-141. Academic Press Inc. Journal of Gynecologic Oncology (JGO)